Doxazosin Mesylate Extended-Release Tablets GMP
Click to enlarge

Doxazosin Mesylate Extended-Release Tablets GMP

China HebeiShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.20 - 0.50

MOQ20000 pieces

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

石家庄四药有限公司
China HebeiShimen Mansion, No. 1, Siyao Road, Economic & Development Zone, Shijiazhuang, Hebei, China
  • Business Type: Manufacturer/Factory
  • Avg. Response Time: ≤ 18.94h
  • System Certification: ISO 9001,ISO 14001,GMP

Main Products

  • Injection
  • Medicine
  • Western Medicine
  • Infusion
  • IV Solution
  • Parenteral Solution
  • Tablet
  • Capsule
  • Small Volume Injection
  • Inhalation

Main Markets

South America,Mid East,Southeast Asia,Oceania,Africa